The Morbidity Management and Disability Prevention (MMDP) Project is a five-year effort funded by the U.S. Agency for International Development to support national governments in their work to eliminate trachoma and lymphatic filariasis. Our mandate is to ensure high-quality treatment and care for people afflicted with these diseases.
For those suffering from trachomatous trichiasis, the final, blinding stage of trachoma, we strengthen in-country capacity to offer sight-preserving eyelid surgery. For men with hydrocele, the severe swelling of the scrotum caused by lymphatic filariasis, we support countries in their work to provide high-quality surgical treatment. Meanwhile, we offer technical assistance for the training of health workers to care for people afflicted with lymphedema. The MMDP Project is managed by Helen Keller International. Read more
Monitoring and evaluation is central to the MMDP Project. Our rigorous framework measures not only the number of people reached but the quality of those services, and is aligned with national M&E systems that track progress toward trachoma and lymphatic filariasis elimination. Lessons learned through M&E will add to the global knowledge and evidence base on effective program implementation. Read more
The MMDP Project is currently focused on three countries in Africa: Burkina Faso, Cameroon and Ethiopia. Each of these countries is characterized by significant disease burden and has requested external support to achieve disease elimination goals through the provision of enhanced services for trichiasis, hydrocele and lymphedema patients. As USAID’s flagship project for morbidity management and disability prevention in the area of neglected tropical diseases, the MMDP Project also provides short-term technical assistance to other countries in the USAID NTD portfolio.